Literature DB >> 1500179

Comparison of the abilities of Mycobacterium avium and Mycobacterium intracellulare to infect and multiply in cultured human macrophages from normal and human immunodeficiency virus-infected subjects.

A J Crowle1, E R Ross, D L Cohn, J Gilden, M H May.   

Abstract

Patients with AIDS commonly develop disseminated infections with Mycobacterium avium (MA) but not its close relative, M. intracellulare (MI). In non-AIDS patients who have these infections, the two species are about equally distributed. The higher incidence of infection with MA than with MI in AIDS patients might be due to the selective susceptibility of these patients to MA. This possibility was tested by comparing the abilities of MA and MI to infect and replicate in cultured macrophages from normal subjects and from patients with AIDS-related complex or AIDS. The macrophages were cultured in medium supplemented with 1 or 5% normal or patient sera or with 1% defined serum substitute. Replication of MA (serovar 4) or MI (serovars 16 and 17) in the macrophages was measured by CFU counts made from lysed samples of the macrophages taken at 0,4, and 7 days after macrophage infection. MA and MI in infected normal macrophages which were cultured in normal serum replicated in these macrophages at similar rates. MA but not MI multiplied abnormally rapidly in patient macrophages cultured in either normal serum or patient serum. The accelerated growth of MA in patient macrophages was macrophage dependent, because patient sera did not change the rate of MA replication in culture medium lacking macrophages. However, patient sera did increase the permissiveness of normal macrophages to MA but not MI. These results suggest that a selective increased susceptibility to MA compared with a retained normal resistance to MI in human immunodeficiency virus-infected patients as they progress from AIDS-related complex to AIDS accounts for the higher prevalence of MA than MI infection in AIDS patients. The results also indicate that the mechanisms of native resistance in human macrophages to MA and MI are different.

Entities:  

Mesh:

Year:  1992        PMID: 1500179      PMCID: PMC257379          DOI: 10.1128/iai.60.9.3697-3703.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Relative permissiveness of macrophages from black and white people for virulent tubercle bacilli.

Authors:  A J Crowle; N Elkins
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

2.  Intrinsic catalase dot blot immunoassay for identification of Mycobacterium tuberculosis, Mycobacterium avium, and Mycobacterium intracellulare.

Authors:  L G Wayne; G A Diaz
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

Review 3.  Mycobacterium avium-complex infections and development of the acquired immunodeficiency syndrome: casual opportunist or causal cofactor?

Authors:  F M Collins
Journal:  Int J Lepr Other Mycobact Dis       Date:  1986-09

Review 4.  Opportunistic pathogens in the genus Mycobacterium.

Authors:  R C Good
Journal:  Annu Rev Microbiol       Date:  1985       Impact factor: 15.500

5.  Plasmid profiles of mycobacterium avium/intracellulare isolated from patients with AIDS or cervical lymphadenitis and from environmental samples.

Authors:  A G Jensen; J Bennedsen; V T Rosdahl
Journal:  Scand J Infect Dis       Date:  1989

6.  Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS.

Authors:  L S Guthertz; B Damsker; E J Bottone; E G Ford; T F Midura; J M Janda
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

7.  Susceptibility of Mycobacterium avium and Mycobacterium intracellulare to various antibacterial drugs.

Authors:  H Tomioka; K Sato; H Saito; Y Yamada
Journal:  Microbiol Immunol       Date:  1989       Impact factor: 1.955

8.  Inhibition by normal human serum of Mycobacterium avium multiplication in cultured human macrophages.

Authors:  A J Crowle; P Poche
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

9.  Defects in sera from acquired immunodeficiency syndrome (AIDS) patients and from non-AIDS patients with Mycobacterium avium infection which decrease macrophage resistance to M. avium.

Authors:  A J Crowle; D L Cohn; P Poche
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

Review 10.  Mycobacterial disease, immunosuppression, and acquired immunodeficiency syndrome.

Authors:  F M Collins
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

View more
  8 in total

1.  'Big MAC' attack.

Authors:  S Shafran; J Conly
Journal:  Can J Infect Dis       Date:  1993-03

Review 2.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

3.  Mycobacterium avium bacilli grow saprozoically in coculture with Acanthamoeba polyphaga and survive within cyst walls.

Authors:  M Steinert; K Birkness; E White; B Fields; F Quinn
Journal:  Appl Environ Microbiol       Date:  1998-06       Impact factor: 4.792

4.  Phenotypic and genomic analyses of the Mycobacterium avium complex reveal differences in gastrointestinal invasion and genomic composition.

Authors:  J A McGarvey; L E Bermudez
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Qualitative immune modulation by interleukin-2 (IL-2) adjuvant therapy in immunological non responder HIV-infected patients.

Authors:  Francesca Sabbatini; Alessandra Bandera; Giulio Ferrario; Daria Trabattoni; Giulia Marchetti; Fabio Franzetti; Mario Clerici; Andrea Gori
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

6.  Envelope glycoprotein (gp120) from HIV-1 enhances Mycobacterium avium growth in human bronchoalveolar macrophages; an effect mediated by enhanced prostaglandin synthesis.

Authors:  M Denis
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

Review 7.  Mycobacterium avium in the postgenomic era.

Authors:  Christine Y Turenne; Richard Wallace; Marcel A Behr
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

8.  Modulation of the effector function of human monocytes for Mycobacterium avium by human immunodeficiency virus-1 envelope glycoprotein gp120.

Authors:  H Shiratsuchi; J L Johnson; Z Toossi; J J Ellner
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.